Cargando…
De-Escalation Therapy After PCI in ACS Patients With Chronic Kidney Disease
[Figure: see text]
Autores principales: | Natsuaki, Masahiro, Node, Koichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982280/ https://www.ncbi.nlm.nih.gov/pubmed/36873761 http://dx.doi.org/10.1016/j.jacasi.2022.10.010 |
Ejemplares similares
-
Escalation and De-Escalation of Antiplatelet Therapy after Acute Coronary Syndrome or PCI: Available Evidence and Implications for Practice
por: Gragnano, Felice, et al.
Publicado: (2022) -
Single-Session Versus Staged Multivessel Optimal IVUS-Guided PCI in Patients With CCS or NSTE-ACS
por: Yamamoto, Ko, et al.
Publicado: (2023) -
Early de-escalation of DAPT after PCI: implications of the latest randomized trials in the COVID era
por: Mahajan, Kunal, et al.
Publicado: (2020) -
No free lunch—the price of double versus triple antithrombotic therapy in patients with atrial fibrillation after ACS or PCI
por: Valgimigli, Marco, et al.
Publicado: (2020) -
An analysis of patients receiving emergency CAG without PCI and the value of GRACE score in predicting PCI possibilities in NSTE-ACS patients
por: Zhou, Bo-Da, et al.
Publicado: (2015)